John T Henderson Cytokinetics Inc (CYTK) insider trading activity

John T Henderson is Director of CYTOKINETICS INC. Currently has a direct ownership of 38,461 shares of CYTK, which is worth approximately $1.89 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 403 shares (Common Stock) at a price of $52.6 per share, resulting in proceeds of $21,197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.5K

1.06% 3M change

20.88% 12M change

Total Value Held $1.89 Million

JOHN T HENDERSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2024	BUY Grant, award, or other acquisition	$21,197 $52.6 p/Share	403 Added 1.04%	38,461 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	388 Added 1.01%	38,058 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	5,600 Added 12.94%	37,670 Common Stock
Apr 25 2024	SELL Open market or private sale	$681,671 $64.54 p/Share	10,562 Reduced 24.77%	32,070 Common Stock
Feb 14 2024	SELL Open market or private sale	$382,400 $76.48 p/Share	5,000 Reduced 10.5%	42,632 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$22,200 $4.44 p/Share	5,000 Added 9.5%	47,632 Common Stock
Jan 12 2024	SELL Open market or private sale	$425,700 $85.14 p/Share	5,000 Reduced 10.5%	42,632 Common Stock
Jan 12 2024	BUY Exercise of conversion of derivative security	$22,200 $4.44 p/Share	5,000 Added 9.5%	47,632 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	$21,198 $84.12 p/Share	252 Added 0.59%	42,632 Common Stock
Dec 18 2023	SELL Open market or private sale	$89,323 $36.34 p/Share	2,458 Reduced 5.48%	42,380 Common Stock
Dec 18 2023	BUY Exercise of conversion of derivative security	$87,494 $6.72 p/Share	13,020 Added 22.5%	44,838 Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	$21,244 $27.88 p/Share	762 Added 2.34%	31,818 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	$21,216 $33.36 p/Share	636 Added 2.01%	31,056 Common Stock
May 15 2023	SELL Open market or private sale	$157,349 $37.77 p/Share	4,166 Reduced 14.08%	25,420 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	$28,245 $6.78 p/Share	4,166 Added 12.34%	29,586 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	5,000 Added 14.12%	30,420 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	$19,986 $37.71 p/Share	530 Added 2.04%	25,420 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	$19,957 $44.35 p/Share	450 Added 1.78%	24,890 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	$19,984 $51.11 p/Share	391 Added 1.57%	24,440 Common Stock
Sep 12 2022	SELL Open market or private sale	$1,195,439 $54.94 p/Share	21,759 Reduced 47.5%	24,049 Common Stock
Sep 12 2022	BUY Exercise of conversion of derivative security	$87,471 $4.02 p/Share	21,759 Added 41.0%	31,308 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	$19,967 $41.0 p/Share	487 Added 1.98%	24,049 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 17.51%	23,562 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	$18,729 $38.38 p/Share	488 Added 2.56%	18,562 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$22,746 $5.46 p/Share	4,166 Added 18.73%	18,074 Common Stock

JTH

John T Henderson

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account